Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Triple modality image reconstruction of PET data using SPECT, PET, CT information increases lesion uptake in images of patients treated with radioembolization with [Formula: see text] micro-spheres.

Deidda D. et al, (2023), EJNMMI Phys, 10

Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Methods from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Supplementary Methods from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

Skwarski M. et al, (2023)

Variability of estimated glomerular filtration rate and 99mTc-DTPA glomerular filtration rate: implications for a single time-point sampling regime.

Bonney LM. and McGowan DR., (2023), Nucl Med Commun

Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.

Bourigault P. et al, (2022), Sci Rep, 12

The role of [18F]fluorodopa positron emission tomography in grading of gliomas.

Roach JR. et al, (2022), J Neurooncol

Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder.

Barber TR. et al, (2022), Brain

Tailoring the sampling time of single-sample GFR measurement according to expected renal function: a multisite audit.

McMeekin H. et al, (2022), EJNMMI Phys, 9

Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.

Ralli GP. et al, (2022), Breast Cancer Res, 24

Effects of Respiratory Motion on Y-90 PET Dosimetry for SIRT.

Walker MD. et al, (2022), Diagnostics (Basel), 12

Change in activity uptake between treatment cycles in quantitative Lu-177 SPECT/CT

Bonney L. and McGowan DR., (2022), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49, S644 - S644

Multimodal PET/CT Tumour Segmentation and Prediction of Progression-Free Survival Using a Full-Scale UNet with Attention

Bourigault E. et al, (2022), Lecture Notes in Computer Science, 189 - 201

TOF image enhancement of non-TOF PET scans using deep learning: a generalizability study

Mehranian A. et al, (2022), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49, S618 - S618

Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients.

Bourigault P. et al, (2021), EJNMMI Res, 11

Load More

1
2
3
4
5
6